이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Regis 관리

관리 기준 확인 3/4

Regis' CEO는 Matt Doctor, Dec2021 에 임명되었습니다 의 임기는 2.5 년입니다. 총 연간 보상은 $ 1.94M, 30.9% 로 구성됩니다. 30.9% 급여 및 69.1% 보너스(회사 주식 및 옵션 포함). 는 € 5.21K 가치에 해당하는 회사 주식의 0.053% 직접 소유합니다. 5.21K. 경영진과 이사회의 평균 재임 기간은 각각 2.5 년과 6.2 년입니다.

주요 정보

Matt Doctor

최고 경영자

US$1.9m

총 보상

CEO 급여 비율	30.9%
CEO 임기	2.5yrs
CEO 소유권	0.05%
경영진 평균 재임 기간	2.5yrs
이사회 평균 재임 기간	6.2yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Matt Doctor 의 보수는 Regis 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	n/a	n/a	-US$7m
Sep 30 2023	n/a	n/a	-US$8m
Jun 30 2023	US$2m	US$600k	-US$11m
Mar 31 2023	n/a	n/a	-US$15m
Dec 31 2022	n/a	n/a	-US$37m
Sep 30 2022	n/a	n/a	-US$39m
Jun 30 2022	US$5m	US$463k	-US$46m

보상 대 시장: Matt 의 총 보상 ($USD 1.94M )은 German 시장( $USD 434.78K ).

보상과 수익: Matt 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Matt Doctor (37 yo)

2.5yrs

테뉴어

US$1,938,862

보상

Mr. Matthew Doctor, also known as Matt, has been the President, Chief Executive Officer and Director of Regis Corporation since May 2022. He served as Interim Chief Executive Officer Regis Corporation sinc...

리더십 팀

이름	위치	테뉴어	보상	소유권
Matthew Doctor	President	2.5yrs	US$1.94m	0.053% $ 25.8k
Kersten Zupfer	Executive VP & CFO	4.6yrs	US$1.03m	0.16% $ 78.7k
John Davi	Executive VP & Chief Digital Officer	2.4yrs	US$961.88k	0.064% $ 31.2k
Jim Lain	Executive VP & COO	2.5yrs	US$1.18m	데이터 없음
Mark Fosland	Senior Vice President of Finance & Investor Relations	13.4yrs	데이터 없음	데이터 없음
Jennifer Reise	Assistant VP of Corporate Compliance & Assistant Secretary	no data	데이터 없음	데이터 없음
Michelle DeVore	Senior VP & Head of Marketing	1.8yrs	데이터 없음	데이터 없음
Michael Ferranti	Executive VP & Chief People Officer	3.3yrs	데이터 없음	0.11% $ 54.4k
Jackie Lang	Senior VP & International MD of UK	no data	데이터 없음	데이터 없음
James Suarez	Executive Vice President of Merchandising & Education	2.3yrs	데이터 없음	0.19% $ 90.6k
Elizabeth McShane Murphy	VP & Corporate Controller	no data	데이터 없음	데이터 없음
David Kunin	Vice President - The Regis Foundation	no data	US$38.52k	데이터 없음

2.5yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: RGI0 의 관리팀은 경험 ( 2.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Matthew Doctor	President	2.1yrs	US$1.94m	0.053% $ 25.8k
Michael Merriman	Independent Director	12.8yrs	US$207.90k	데이터 없음
Margaret Rhoades	Independent Director	9.4yrs	US$202.90k	0% $ 0
Michael Mansbach	Independent Director	3yrs	US$197.90k	0% $ 0
Nancy Benacci	Director	1.1yrs	US$56.68k	0% $ 0
David Grissen	Independent Chairman	10.7yrs	US$286.15k	0.062% $ 30.2k
Mark Light	Independent Director	10.7yrs	US$200.40k	0% $ 0
Lockie Andrews	Independent Director	2.8yrs	US$187.90k	0% $ 0

6.2yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: RGI0 의 이사회는 경험(평균 재직 기간 6.2 년)으로 간주됩니다.

Regis 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Regis Corporation, Annual General Meeting, Oct 24, 2023

Regis Corporation Appoints Ms. Nancy Benaccito the Board of Directors of the Company, Effective May 1, 2023

Regis Corporation, Annual General Meeting, Oct 25, 2022

Regis Corporation appoints Michelle DeVore as Senior Vice President, Head of Marketing

Regis Corporation Appoints Matthew Doctor as Chief Executive Officer

Regis Corporation Announces Management Appointments

Recent updates

Regis Corporation to Report Q3, 2024 Results on May 01, 2024

Regis Corporation Reports Impairment for the Second Quarter Ended December 31, 2023

Regis Corporation to Report Q2, 2024 Results on Jan 31, 2024

William Charters Issues Letter to Regis Corporation

Galloway Capital Partners, LLC Issues a Letter to Regis Corporation

Regis Announces Appeal of NYSE Determination to Commence Proceedings to Delist Regis' Common Stock

NYSE Regulation Determines to Commence Proceedings to Delist Regis' Common Stock from the NYSE

NYSE to Commence Delisting Proceedings Against Regis Corporation

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

New major risk - Financial data availability

First quarter 2024 earnings released: EPS: US$0.026 (vs US$0.04 loss in 1Q 2023)

Regis Corporation to Report Q1, 2024 Results on Nov 01, 2023

New major risk - Share price stability

Regis Corporation, Annual General Meeting, Oct 24, 2023

Regis Corporation Reports Impairment Charges for the Fourth Quarter Ended June 30, 2023

Full year 2023 earnings released: US$0.24 loss per share (vs US$1.07 loss in FY 2022)

Regis Corporation to Report Q4, 2023 Results on Aug 23, 2023

Regis Corporation Appoints Ms. Nancy Benaccito the Board of Directors of the Company, Effective May 1, 2023

Regis Corporation Reports Impairment Charges for the Third Quarter Ended March 31, 2023

Third quarter 2023 earnings released: US$0.047 loss per share (vs US$0.61 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.055 loss per share (vs US$0.11 loss in 2Q 2022)

Regis Corporation to Report Q2, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: US$0.04 loss per share (vs US$0.28 loss in 1Q 2022)

Regis Corporation to Report Q1, 2023 Results on Nov 01, 2022

Regis Corporation, Annual General Meeting, Oct 25, 2022

Regis Corporation appoints Michelle DeVore as Senior Vice President, Head of Marketing

Regis Corporation to Report Q4, 2022 Results on Aug 23, 2022

SOHAM INC completed the acquisition of Opensalon Pro from Regis Corporation (NYSE : RGS).

Regis Corporation(NYSE:RGS) dropped from Russell Microcap Value Index

SOHAM INC agreed to acquire Opensalon Pro from Regis Corporation (NYSE : RGS) for $39 million.

Third quarter 2022 earnings released: US$0.61 loss per share (vs US$0.30 loss in 3Q 2021)

Regis Corporation Appoints Matthew Doctor as Chief Executive Officer

Forecast to breakeven in 2023

Regis Corporation Announces Management Appointments

Regis Corporation Announces Impairment Charges for the Second Quarter Ended December 31, 2021

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Chief Development Officer, Executive VP, General Counsel & Secretary Amanda Rusin has left the company

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.98 loss in 1Q 2021)

High number of new directors

Forecast to breakeven in 2023

Full year 2021 earnings released: US$3.15 loss per share (vs US$4.79 loss in FY 2020)

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$2.10 loss in 3Q 2020)

New 90-day high: €10.20

Second quarter 2021 earnings released: US$0.92 loss per share (vs US$0.27 loss in 2Q 2020)

Revenue misses expectations

New 90-day high: €9.60

Regis Corporation to Report Q2, 2021 Results on Feb 04, 2021

New 90-day high: €8.55

Regis Corporation Announces Termination of Eric Bakken's Employment as Executive Vice President and President - Franchise, Effective December 31, 2020

Regis Corporation to Report Q1, 2021 Results on Nov 02, 2020

Regis Corporation Announces Executive Changes

Regis Corporation Announces Revenue Estimate for the Fourth Quarter of 2020

Regis Corporation to Report Q4, 2020 Results on Aug 31, 2020

New 90-day low - €6.20

Regis Corporation(NYSE:RGS) dropped from Russell Microcap Growth Index

Regis Corporation(NYSE:RGS) dropped from Russell 2000 Defensive Index

Regis Corporation(NYSE:RGS) dropped from Russell 2000 Value-Defensive Index

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령